Summary:
This podcast features a panel discussion from the 2024 Chief Medical Officer Summit 360° on how biotech CMOs can set their assets up for success when transitioning from earlier proof-of-concept and safety trials to pivotal trials for regulatory submissions.
To learn more about the CMO Summit 360°, please visit CMO360.org.
Moderators
Arvin Yang, MD, PhD
CMO
Pheon Therapeutics
Panelists
Lise Kjems, MD, PhD
CMO
Ocelot Bio
Johan Baeck, MD
EVP, CMO
Promontory Therapeutics Inc.
May Orfali, MD, MBA
CMO
GEMMA Biotherapeutics
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.